Cargando…
Neuropeptide Y and its Y2 Receptor – Potential Targets in Neuroblastoma Therapy
Neuroblastomas are pediatric tumors which develop from sympathetic precursors and express neuronal proteins, such as neuropeptide Y (NPY). NPY is a sympathetic neurotransmitter acting via multiple receptors (Y1-Y5R). Both NPY and Y2Rs are commonly expressed in neuroblastoma cell lines and tissues. T...
Autores principales: | Lu, Congyi, Everhart, Lindsay, Tilan, Jason, Kuo, Lydia, Sun, Chen-Chih J., Munivenkatappa, Raghava B, Jönsson-Rylander, Ann-Cathrine, Sun, Junfeng, Kuan-Celarier, Anna, Li, Lijun, Abe, Ken, Zukowska, Zofia, Toretsky, Jeffrey A., Kitlinska, Joanna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955165/ https://www.ncbi.nlm.nih.gov/pubmed/20676138 http://dx.doi.org/10.1038/onc.2010.301 |
Ejemplares similares
-
Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
por: Czarnecka, Magdalena, et al.
Publicado: (2014) -
Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects
por: Tilan, Jason U., et al.
Publicado: (2013) -
High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases
por: Hong, Sung-Hyeok, et al.
Publicado: (2015) -
Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System
por: Han, Ruijun, et al.
Publicado: (2012) -
Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation
por: Abualsaud, Nouran, et al.
Publicado: (2021)